**Table 1:** Sample sizes for GWAS meta-analyses. Fixed-effects analyses
are listed separately for each population cluster (AFR, AMR, EAS, EUR,
MID, and SAS) and totals are given for the multi-ancestry analysis
(MR-MEGA). Neff/2 = half effective sample size. ATC = Anatomical
Therapeutic Chemical classification subgroups (N06A: antidepressants;
N06AA: non-selective monoamine reuptake inhibitors; N06AB: selective
serotonin reuptake inhibitors).

| ATC   | Cluster | N studies |   Cases | Controls |     Neff/2 |
|:------|:--------|----------:|--------:|---------:|-----------:|
| N06A  | AFR     |         2 |  14,021 |   34,482 |  19,932.94 |
| N06A  | AMR     |         2 |   8,351 |   28,099 |  12,874.46 |
| N06A  | EAS     |         3 |   4,091 |  179,842 |   7,812.32 |
| N06A  | EUR     |         4 | 213,129 |  329,556 | 241,786.28 |
| N06A  | MID     |         2 |     340 |    1,069 |     511.63 |
| N06A  | SAS     |         2 |   1,991 |    5,597 |   2,907.00 |
| N06AA | AFR     |         2 |   4,227 |   44,277 |   7,655.16 |
| N06AA | EUR     |         3 |  51,117 |  295,841 |  85,892.88 |
| N06AA | SAS     |         2 |   1,178 |    6,399 |   1,892.43 |
| N06AB | AFR     |         2 |   8,276 |   40,228 |  13,718.57 |
| N06AB | EUR     |         3 |  65,762 |  281,196 | 105,138.40 |
| N06AB | MID     |         2 |     202 |    1,202 |     345.08 |
| N06AB | SAS     |         2 |   1,060 |    6,517 |   1,822.48 |
| N06A  | MR-MEGA |        15 | 241,923 |  578,645 | 285,824.63 |
| N06AA | MR-MEGA |        10 |  59,080 |  384,869 | 100,205.27 |
| N06AB | MR-MEGA |        11 |  80,934 |  363,887 | 130,706.98 |

**Table 2:** Drug target enrichment. ATC = Anatomical Therapeutic
Chemical classification subgroup. AUC = Area Under the Curve. Q =
Significance corrected for multiple testing (Benjamini & Hochberg).

<div class="kable-table">

| ATC   | Name                     |   N | round(AUC, 3) | Q value |
|:------|:-------------------------|----:|--------------:|--------:|
| N05A  | Antipsychotics           |  66 |         0.646 |   0.010 |
| J01M  | Quinolone Antibacterials |  28 |         0.764 |   0.010 |
| J01MA | Fluoroquinolones         |  20 |         0.780 |   0.034 |
| N05   | Psycholeptics            | 171 |         0.587 |   0.035 |
| S01A  | Antiinfectives           |  61 |         0.633 |   0.035 |

</div>

**Table 3:** Comparison of results to major depression GWAS.

<div class="kable-table">

|  | N06A (MR-MEGA) | N06A (EUR) | N06AA (EUR) | N06AB (EUR) |
|:---|:---|:---|:---|:---|
| positional_mapping | — | 25/255 (9.8%) p-value=2.58e-15 | 0/9 (0%) p-value=1 | 4/14 (28.57%) p-value=2.32e-05 |
| fine_mapping | 1/2 (50%) p-value=0.0249 | — | — | — |

</div>
